[go: up one dir, main page]

TR199903272T2 - New knowledge of asthma prescription drugs. - Google Patents

New knowledge of asthma prescription drugs.

Info

Publication number
TR199903272T2
TR199903272T2 TR1999/03272T TR9903272T TR199903272T2 TR 199903272 T2 TR199903272 T2 TR 199903272T2 TR 1999/03272 T TR1999/03272 T TR 1999/03272T TR 9903272 T TR9903272 T TR 9903272T TR 199903272 T2 TR199903272 T2 TR 199903272T2
Authority
TR
Turkey
Prior art keywords
new knowledge
prescription drugs
asthma
asthma prescription
composition
Prior art date
Application number
TR1999/03272T
Other languages
Turkish (tr)
Inventor
Axelsson Bengt
Kallstrom Leif
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of TR199903272T2 publication Critical patent/TR199903272T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bulus, bir birinci aktif madde olarak formeterol ya da onun bir tuz ya da türevine ve bir ikinci madde ropfleponid ya da onun bir yagli asit esterine sahip bir kompozisyon ya da grup saglar. Ayrica bu kompozisyon ya da grubu kullanan solunum bozuklugu tedavi metotlari açiklanmaktadir.The invention provides a composition or group having formeterol or a salt or derivative thereof as a first active ingredient and a second substance ropfleponid or a fatty acid ester thereof. Also described are respiratory disorder treatment methods using this composition or group.

TR1999/03272T 1997-06-27 1998-06-08 New knowledge of asthma prescription drugs. TR199903272T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88382397A 1997-06-27 1997-06-27

Publications (1)

Publication Number Publication Date
TR199903272T2 true TR199903272T2 (en) 2000-08-21

Family

ID=25383399

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03272T TR199903272T2 (en) 1997-06-27 1998-06-08 New knowledge of asthma prescription drugs.

Country Status (16)

Country Link
EP (1) EP1009408A1 (en)
JP (1) JP2002510310A (en)
KR (1) KR20010014162A (en)
AU (1) AU8135098A (en)
BR (1) BR9810452A (en)
CA (1) CA2295076A1 (en)
EE (1) EE9900594A (en)
HU (1) HUP0002533A3 (en)
ID (1) ID24063A (en)
IL (1) IL133597A0 (en)
IS (1) IS5303A (en)
NO (1) NO996438L (en)
PL (1) PL337722A1 (en)
SK (1) SK184799A3 (en)
TR (1) TR199903272T2 (en)
WO (1) WO1999000134A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9703407D0 (en) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
SE9900833D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination
GB0009617D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
AU2003263717A1 (en) * 2002-09-25 2004-04-19 Astrazeneca Ab A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (en) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
WO1993011773A1 (en) * 1991-12-18 1993-06-24 Aktiebolaget Astra New combination of formoterol and budesonide
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation
SE9501384D0 (en) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
SE9603669D0 (en) * 1996-10-08 1996-10-08 Astra Ab New combination

Also Published As

Publication number Publication date
EP1009408A1 (en) 2000-06-21
ID24063A (en) 2000-07-06
EE9900594A (en) 2000-08-15
BR9810452A (en) 2000-09-05
JP2002510310A (en) 2002-04-02
NO996438D0 (en) 1999-12-23
PL337722A1 (en) 2000-08-28
CA2295076A1 (en) 1999-01-07
AU8135098A (en) 1999-01-19
HUP0002533A3 (en) 2001-03-28
HUP0002533A2 (en) 2000-12-28
IS5303A (en) 1999-12-15
NO996438L (en) 2000-02-28
KR20010014162A (en) 2001-02-26
WO1999000134A1 (en) 1999-01-07
SK184799A3 (en) 2000-06-12
IL133597A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
NO953278L (en) Methods for in vivo delivery of biologically active substances and compositions useful for this purpose
TR200000229T2 (en) Substituted 1,2,3,4-Tetrahydronaphthalene derivative i
PT1093819E (en) COMPOUNDS AND COMPOSITIONS FOR THE SUPPLY OF ACTIVE AGENTS
ATE286384T1 (en) SUSTAINED RELEASE FORMULATION CONTAINING COLLAGEN AND GLYCOSAMINOGLYCAN
TR199802273T2 (en) Fibrotic lezyonlar�n onar�lmas� ve nlenmesi.
ID21259A (en) DRUG DISTRIBUTION SYSTEMS FOR TWO OR MORE ACTIVE INGREDIENTS
IL112664A0 (en) 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
EE200000065A (en) Aerosol formulations containing biologically active macromolecules and water, and method for their preparation
BR0313627A (en) Pharmaceutical formulations, processes for the preparation of pharmaceutical formulations and method for treating pain
AP1760A (en) Platinum derivative pharmaceutical formulations.
ES2186769T3 (en) STABLE COMPLEXES THAT INCLUDE LIPIDS FOR THE ADMINISTRATION OF DRUGS AND PROCEDURES FOR THEIR PRODUCTION.
DE69835692D1 (en) LOADED LIPIDS AND THEIR USE
ATE195721T1 (en) LIPOPOLYAMINE AS TRANSFECTION AGENT AND THEIR PHARMACEUTICAL APPLICATIONS
NO996349L (en) Pharmaceutical composition having increased antitumor activity and / or reduced side effects, containing an antitumor agent and a hydroxymic acid derivative
ATE267613T1 (en) MEDICINAL PRODUCTS AND THEIR USE
BR0314797A (en) Pyrimidineamide derivatives and their use
BR9507073A (en) Composed processes to prepare the same and to treat a disease in the central nervous system pharmaceutical composition and use of the compound
TR199901433T2 (en) Pyrolo$3,4-D] pyrimidinone derivatives and their use as drugs.
TR199903272T2 (en) New knowledge of asthma prescription drugs.
TR200001147T2 (en) The use of macrolides for the treatment of cancer and macular degeneration
TR199700711T1 (en) Formulation that enters the body by passing through the skin.
TR199903271T2 (en) Tokoferol ile karl�la�t�r�lan soluma i�in prolipozom tozlar�.
ATE157876T1 (en) DRUG-FREE LIPOSOMES FOR THE TREATMENT OF ATHEROSCLERosis
MX9101958A (en) AMINOSULFONYL UREA ACAT INHIBITORS
TR200100637T2 (en) New natural product derivatives